(Q41743553)

8 October 2017

1 reference

title

Preferential benefit of platelet glycoprotein IIb/IIIa receptor blockade: specific considerations by device and disease state (English)

1 reference

8 October 2017

1

D J Kereiakes

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

American Journal of Cardiology

8 October 2017

published in

1 reference

8 October 2017

volume

81

1 reference

8 October 2017

issue

7A

1 reference

8 October 2017

page(s)

49E-54E

1 reference

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Clinical outcome of patients undergoing endoluminal coronary artery reconstruction with three or more stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Final results of the Balloon vs Optimal Atherectomy Trial (BOAT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Assessment of platelet activation by coronary sinus blood sampling during balloon angioplasty and directional coronary atherectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

High speed rotational coronary atherectomy for patients with diffuse coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Risk factors for the development of slow flow during rotational coronary atherectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Meeting highlights: 46th Annual Scientific Sessions of the American College of Cardiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900198-2

10.1016/S0002-9149(98)00198-2

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference